278 related articles for article (PubMed ID: 12433304)
21. Studies on smaller (approximately 315 microM) microcapsules: IV. Feasibility and safety of intrahepatic implantations of small alginate poly-L-lysine microcapsules.
Leblond FA; Simard G; Henley N; Rocheleau B; Huet PM; Hallé JP
Cell Transplant; 1999; 8(3):327-37. PubMed ID: 10442745
[TBL] [Abstract][Full Text] [Related]
22. Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility.
Sawhney AS; Pathak CP; Hubbell JA
Biomaterials; 1993 Oct; 14(13):1008-16. PubMed ID: 8286667
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and transport characterization of alginate/aminopropyl-silicate/alginate microcapsule: application to bioartificial pancreas.
Sakai S; Ono T; Ijima H; Kawakami K
Biomaterials; 2001 Nov; 22(21):2827-34. PubMed ID: 11561887
[TBL] [Abstract][Full Text] [Related]
24. Alginate polycation microcapsules. I. Interaction between alginate and polycation.
Thu B; Bruheim P; Espevik T; Smidsrød O; Soon-Shiong P; Skjåk-Braek G
Biomaterials; 1996 May; 17(10):1031-40. PubMed ID: 8736740
[TBL] [Abstract][Full Text] [Related]
25. Field Effect Microparticle Generation for Cell Microencapsulation.
Hsu BR; Fu SH
Methods Mol Biol; 2017; 1479():57-70. PubMed ID: 27738926
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing insulin secretion from encapsulated islets.
de Haan BJ; Faas MM; de Vos P
Cell Transplant; 2003; 12(6):617-25. PubMed ID: 14579930
[TBL] [Abstract][Full Text] [Related]
27. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules.
Bünger CM; Gerlach C; Freier T; Schmitz KP; Pilz M; Werner C; Jonas L; Schareck W; Hopt UT; de Vos P
J Biomed Mater Res A; 2003 Dec; 67(4):1219-27. PubMed ID: 14624508
[TBL] [Abstract][Full Text] [Related]
28. Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines.
Strand BL; Ryan TL; In't Veld P; Kulseng B; Rokstad AM; Skjak-Brek G; Espevik T
Cell Transplant; 2001; 10(3):263-75. PubMed ID: 11437072
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of microcapsule permeability via inverse size exclusion chromatography.
Brissová M; Petro M; Lacík I; Powers AC; Wang T
Anal Biochem; 1996 Nov; 242(1):104-11. PubMed ID: 8923972
[TBL] [Abstract][Full Text] [Related]
30. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules.
Clayton HA; London NJ; Colloby PS; Bell PR; James RF
J Microencapsul; 1991; 8(2):221-33. PubMed ID: 1765902
[TBL] [Abstract][Full Text] [Related]
31. Maintenance of long-term secretory function by microencapsulated islets of Langerhans.
Lévesque L; Brubaker PL; Sun AM
Endocrinology; 1992 Feb; 130(2):644-50. PubMed ID: 1370793
[TBL] [Abstract][Full Text] [Related]
32. Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules.
Haque T; Chen H; Ouyang W; Martoni C; Lawuyi B; Urbanska AM; Prakash S
Mol Pharm; 2005; 2(1):29-36. PubMed ID: 15804175
[TBL] [Abstract][Full Text] [Related]
33. An understanding of potential and limitations of alginate/PLL microcapsules as a cell retention system for perfusion cultures.
Demont A; Cole H; Marison IW
J Microencapsul; 2016 Feb; 33(1):80-8. PubMed ID: 26754597
[TBL] [Abstract][Full Text] [Related]
34. Monodisperse semi-permeable microcapsules for continuous observation of cells.
Morimoto Y; Tan WH; Tsuda Y; Takeuchi S
Lab Chip; 2009 Aug; 9(15):2217-23. PubMed ID: 19606299
[TBL] [Abstract][Full Text] [Related]
35. Polymeric Materials for Perm-Selective Coating of Alginate Microbeads.
Kendall WF; Opara EC
Methods Mol Biol; 2017; 1479():95-109. PubMed ID: 27738929
[TBL] [Abstract][Full Text] [Related]
36. Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes.
Sawhney AS; Hubbell JA
Biomaterials; 1992; 13(12):863-70. PubMed ID: 1457680
[TBL] [Abstract][Full Text] [Related]
37. Considerations in binding diblock copolymers on hydrophilic alginate beads for providing an immunoprotective membrane.
Spasojevic M; Bhujbal S; Paredes G; de Haan BJ; Schouten AJ; de Vos P
J Biomed Mater Res A; 2014 Jun; 102(6):1887-96. PubMed ID: 23853069
[TBL] [Abstract][Full Text] [Related]
38. The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets.
King A; Lau J; Nordin A; Sandler S; Andersson A
Diabetes Technol Ther; 2003; 5(4):653-63. PubMed ID: 14511420
[TBL] [Abstract][Full Text] [Related]
39. Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions.
Ma X; Vacek I; Sun A
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(1):43-69. PubMed ID: 8055097
[TBL] [Abstract][Full Text] [Related]
40. Reduction of the inflammatory responses against alginate-poly-L-lysine microcapsules by anti-biofouling surfaces of PEG-b-PLL diblock copolymers.
Spasojevic M; Paredes-Juarez GA; Vorenkamp J; de Haan BJ; Schouten AJ; de Vos P
PLoS One; 2014; 9(10):e109837. PubMed ID: 25347191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
